Small cap meal kit stock Blue Apron Holdings (NYSE: APRN) is the 7th most shorted stock on the NYSE with short interest of 46.03% according to Highshortinterest.com. Launched in 2012, Blue Apron Holdings mission is to make incredible home cooking accessible to everyone as the company reimagines the way that food is produced, distributed and consumed. The Company has developed an integrated ecosystem that enables the company to work in a direct, coordinated manner with farmers and artisans to deliver high-quality products to customers nationwide at compelling values. Blue Apron Holdings' current products include Blue Apron Meals, Blue Apron Wine, the Blue Apron Market and BN Ranch, a premium supplier of grass-fed beef and pasture-raised poultry.
However, shares have lost half their value for retail investors since the IPO two months ago:
Top Small Cap Stocks To Invest In 2019: Petroquest Energy Inc(PQ)
Advisors' Opinion:- [By Ethan Ryder]
News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Top Small Cap Stocks To Invest In 2019: FuelCell Energy Inc.(FCEL)
Advisors' Opinion:- [By Paul Ausick]
FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 17.8% in short interest during the period. Some 6.9 million shares were short as of May 15. The stock closed at $1.88 on Thursday, down about 1.1% for the day, in a 52-week range of $0.93 to $2.49. Shares traded up about 1.4% in the short interest period, and days to cover rose from eight to 14.
- [By Ethan Ryder]
FuelCell Energy (NASDAQ: FCEL) and Integer (NYSE:ITGR) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.
- [By Paul Ausick]
FuelCell Energy Inc. (NASDAQ: FCEL) posted a dip of 1.9% in short interest during the two-week period. Some 10.41 million shares were short as of July 31. The stock closed at $1.20 on Thursday, up more than 11% for the day, in a 52-week range of $1.07 to $2.49. Shares traded down about 2.6% in the short interest period, and days to cover slipped from 11 to nine.
Top Small Cap Stocks To Invest In 2019: ATA Inc.(ATAI)
Advisors' Opinion:- [By Paul Ausick]
ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.
Top Small Cap Stocks To Invest In 2019: Achillion Pharmaceuticals Inc.(ACHN)
Advisors' Opinion:- [By Logan Wallace]
Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares shot up 8.6% on Thursday . The company traded as high as $3.59 and last traded at $3.54. 1,383,547 shares changed hands during trading, a decline of 5% from the average session volume of 1,456,445 shares. The stock had previously closed at $3.26.
- [By Logan Wallace]
BidaskClub upgraded shares of Achillion Pharmaceuticals (NASDAQ:ACHN) from a strong sell rating to a sell rating in a research report sent to investors on Tuesday morning.
- [By Stephan Byrd]
Shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) have earned a consensus rating of “Hold” from the six research firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $4.50.
No comments:
Post a Comment